|
Market Closed -
London S.E.
11:35:13 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 576.00 GBX | 0.00% |
|
-0.17% | +5.21% |
| 07-27 | EARNINGS AND TRADING: Science Group profit slips; RTC holds dividend | AN |
| 07-27 | Science Group Sees 2026 Buyback Program Exceeding GBP20 Million | MT |
| Fiscal Period: December | 2016 (GBP) | 2017 (GBP) | 2018 (GBP) | 2019 (GBP) | 2020 (GBP) | 2021 (GBP) | 2022 (GBP) | 2023 (GBP) | 2024 (GBP) | 2025 (GBP) |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 7.6 | 5.7 | 4 | 6.79 | 6.93 | |||||
Return on Total Capital | 10.98 | 7.82 | 5.5 | 9.55 | 9.72 | |||||
Return On Equity % | 17.76 | 14.61 | 7.07 | 14.81 | 35.52 | |||||
Return on Common Equity | 17.76 | 14.61 | 7.07 | 14.81 | 35.52 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 43.54 | 44.44 | 40.81 | 40.82 | 41.23 | |||||
SG&A Margin | 27.97 | 31.58 | 33.47 | 27.38 | 26.11 | |||||
EBITDA Margin % | 20.01 | 17.98 | 12.31 | 17.89 | 19.26 | |||||
EBITA Margin % | 19.13 | 17.22 | 11.7 | 17.41 | 18.78 | |||||
EBIT Margin % | 15.57 | 12.86 | 7.34 | 13.45 | 15.12 | |||||
Income From Continuing Operations Margin % | 11.77 | 12.23 | 4.87 | 10.86 | 29.8 | |||||
Net Income Margin % | 11.77 | 12.23 | 4.87 | 10.86 | 29.8 | |||||
Net Avail. For Common Margin % | 11.77 | 12.23 | 4.87 | 10.86 | 29.8 | |||||
Normalized Net Income Margin | 8.41 | 8.04 | 4.2 | 8.32 | 9.76 | |||||
Levered Free Cash Flow Margin | 10.46 | 15.31 | 5.71 | 12.69 | 23.78 | |||||
Unlevered Free Cash Flow Margin | 10.95 | 15.8 | 6.14 | 13.15 | 24.33 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.78 | 0.71 | 0.87 | 0.81 | 0.73 | |||||
Fixed Assets Turnover | 3.44 | 3.65 | 4.59 | 4.35 | 4.59 | |||||
Receivables Turnover (Average Receivables) | 8.26 | 8.04 | 7.21 | 5.13 | 5.46 | |||||
Inventory Turnover (Average Inventory) | 24.67 | 19.45 | 35.23 | 52.41 | 59.5 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.58 | 1.85 | 1.66 | 1.86 | 2.38 | |||||
Quick Ratio | 1.37 | 1.63 | 1.51 | 1.66 | 2.22 | |||||
Operating Cash Flow to Current Liabilities | 0.41 | 0.44 | 0.22 | 0.47 | 0.54 | |||||
Days Sales Outstanding (Average Receivables) | 44.16 | 45.38 | 50.62 | 71.29 | 66.83 | |||||
Days Outstanding Inventory (Average Inventory) | 14.79 | 18.77 | 10.36 | 6.98 | 6.13 | |||||
Average Days Payable Outstanding | 20.63 | 16.28 | 16.04 | 22.77 | 20.38 | |||||
Cash Conversion Cycle (Average Days) | 38.32 | 47.87 | 44.94 | 55.5 | 52.59 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 25.46 | 20.49 | 21.67 | 18.45 | 13.76 | |||||
Total Debt / Total Capital | 20.29 | 17 | 17.81 | 15.57 | 12.1 | |||||
LT Debt/Equity | 21.91 | 18.03 | 19.33 | 16.05 | 12.47 | |||||
Long-Term Debt / Total Capital | 17.46 | 14.97 | 15.89 | 13.55 | 10.96 | |||||
Total Liabilities / Total Assets | 42.82 | 38.56 | 41.12 | 40.46 | 36.78 | |||||
EBIT / Interest Expense | 19.01 | 15.65 | 8.87 | 15.34 | 13.36 | |||||
EBITDA / Interest Expense | 25.63 | 23.05 | 16.01 | 21.3 | 17.68 | |||||
(EBITDA - Capex) / Interest Expense | 24.82 | 22.92 | 15.93 | 21.3 | 17.66 | |||||
Total Debt / EBITDA | 0.99 | 0.98 | 1.13 | 0.75 | 0.64 | |||||
Net Debt / EBITDA | -1.02 | -1.69 | -0.94 | -1.12 | -2.61 | |||||
Total Debt / (EBITDA - Capex) | 1.02 | 0.99 | 1.13 | 0.75 | 0.64 | |||||
Net Debt / (EBITDA - Capex) | -1.06 | -1.7 | -0.94 | -1.12 | -2.62 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 10.25 | 6.26 | 31.33 | -2.36 | 0.9 | |||||
Gross Profit, 1 Yr. Growth % | 18.64 | 8.47 | 20.59 | -2.32 | 1.9 | |||||
EBITDA, 1 Yr. Growth % | 54.19 | -4.52 | -10.09 | 41.89 | 8.64 | |||||
EBITA, 1 Yr. Growth % | 61.2 | -4.32 | -10.79 | 45.34 | 8.8 | |||||
EBIT, 1 Yr. Growth % | 77.33 | -12.23 | -25.07 | 78.99 | 13.44 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 35.83 | 10.4 | -47.66 | 117.6 | 176.81 | |||||
Net Income, 1 Yr. Growth % | 35.83 | 10.4 | -47.66 | 117.6 | 176.81 | |||||
Normalized Net Income, 1 Yr. Growth % | 70.95 | 1.55 | -31.34 | 93.45 | 18.35 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 29.94 | 4.15 | -46.9 | 116.67 | 183.08 | |||||
Accounts Receivable, 1 Yr. Growth % | 15.48 | 3.75 | 87.66 | 10.23 | -19.1 | |||||
Inventory, 1 Yr. Growth % | 94.3 | 0.94 | -46.23 | -12.39 | -10.97 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -1.79 | 2.07 | 6.75 | -3.3 | -5.61 | |||||
Total Assets, 1 Yr. Growth % | 25.95 | 9.78 | 4.07 | 6.22 | 15.83 | |||||
Tangible Book Value, 1 Yr. Growth % | 124.01 | 35.87 | -36.53 | 29.5 | 54.86 | |||||
Common Equity, 1 Yr. Growth % | 60.16 | 17.96 | -0.27 | 7.2 | 22.99 | |||||
Cash From Operations, 1 Yr. Growth % | -20.77 | 8.97 | -48.19 | 133.52 | 25.37 | |||||
Capital Expenditures, 1 Yr. Growth % | 280.42 | -83.09 | -13.04 | - | - | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -42.02 | 55.55 | -51.29 | 122.74 | 86.84 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -41.1 | 53.36 | -48.95 | 109.09 | 86.68 | |||||
Dividend Per Share, 1 Yr. Growth % | -16.67 | 0 | 60 | 0 | 25 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 19.11 | 8.24 | 18.13 | 13.24 | -0.74 | |||||
Gross Profit, 2 Yr. CAGR % | 23.04 | 13.44 | 14.37 | 8.53 | -0.23 | |||||
EBITDA, 2 Yr. CAGR % | 135.19 | 21.33 | -7.35 | 12.95 | 24.16 | |||||
EBITA, 2 Yr. CAGR % | 168.04 | 24.19 | -7.61 | 13.87 | 25.75 | |||||
EBIT, 2 Yr. CAGR % | 731.16 | 24.76 | -18.9 | 15.81 | 42.49 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 128.51 | 22.45 | -23.99 | 6.71 | 145.42 | |||||
Net Income, 2 Yr. CAGR % | 139.34 | 22.45 | -23.99 | 6.71 | 145.42 | |||||
Normalized Net Income, 2 Yr. CAGR % | 184.94 | 31.75 | -16.5 | 15.25 | 51.31 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 130.23 | 16.33 | -25.64 | 7.26 | 147.66 | |||||
Accounts Receivable, 2 Yr. CAGR % | 9.37 | 9.46 | 39.53 | 43.82 | -5.57 | |||||
Inventory, 2 Yr. CAGR % | 9.14 | 40.04 | -26.33 | -31.36 | -11.68 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -4.93 | 0.12 | 4.38 | 2.35 | -4.46 | |||||
Total Assets, 2 Yr. CAGR % | 19.52 | 17.59 | 6.89 | 5.29 | 10.92 | |||||
Tangible Book Value, 2 Yr. CAGR % | 104.33 | 74.46 | -7.14 | -8.82 | 41.61 | |||||
Common Equity, 2 Yr. CAGR % | 35.2 | 37.45 | 8.46 | 3.65 | 14.82 | |||||
Cash From Operations, 2 Yr. CAGR % | 61.39 | -7.08 | -24.86 | 9.99 | 71.11 | |||||
Capital Expenditures, 2 Yr. CAGR % | -1 | -19.79 | -61.65 | - | -35.77 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 54.97 | -5.03 | -12.69 | 2.81 | 105.21 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 49.21 | -4.96 | -11.52 | 3.32 | 97.57 | |||||
Dividend Per Share, 2 Yr. CAGR % | - | -8.71 | 26.49 | 26.49 | 11.8 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 18.61 | 14.66 | 15.45 | 10.87 | 8.97 | |||||
Gross Profit, 3 Yr. CAGR % | 72.25 | 17.98 | 15.78 | 8.51 | 6.27 | |||||
EBITDA, 3 Yr. CAGR % | 28.39 | 74.15 | 9.8 | 6.8 | 11.5 | |||||
EBITA, 3 Yr. CAGR % | 30.94 | 90.14 | 11.22 | 7.45 | 12.15 | |||||
EBIT, 3 Yr. CAGR % | 37.01 | 292.86 | 5.26 | 5.59 | 15.01 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 30.65 | 79.3 | -7.76 | 7.93 | 46.62 | |||||
Net Income, 3 Yr. CAGR % | 30.65 | 84.93 | -7.76 | 7.93 | 46.62 | |||||
Normalized Net Income, 3 Yr. CAGR % | 34.67 | 102.02 | 6.03 | 10.49 | 16.28 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 27.38 | 76.74 | -10.43 | 6.21 | 48.23 | |||||
Accounts Receivable, 3 Yr. CAGR % | 5.96 | 7.46 | 31 | 28.99 | 18.72 | |||||
Inventory, 3 Yr. CAGR % | - | 6.34 | 1.79 | -21.95 | -25.14 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 0.04 | -2.65 | 2.28 | 2.26 | -0.37 | |||||
Total Assets, 3 Yr. CAGR % | 15.44 | 16.18 | 12.9 | 6.77 | 8.69 | |||||
Tangible Book Value, 3 Yr. CAGR % | 20.18 | 78.34 | 24.54 | 4.14 | 8.78 | |||||
Common Equity, 3 Yr. CAGR % | 17.41 | 29.19 | 23.51 | 8.21 | 9.73 | |||||
Cash From Operations, 3 Yr. CAGR % | 35.41 | 41.59 | -23.52 | 9.65 | 14.9 | |||||
Capital Expenditures, 3 Yr. CAGR % | 7.01 | -45.07 | -17.6 | - | -28.95 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 29.01 | 55.16 | -23.82 | 18.27 | 25.96 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 28.16 | 50.58 | -22.74 | 17.86 | 25.84 | |||||
Dividend Per Share, 3 Yr. CAGR % | 2.82 | - | 10.06 | 16.96 | 25.99 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 17.09 | 16.15 | 18.42 | 14.09 | 8.68 | |||||
Gross Profit, 5 Yr. CAGR % | 43.24 | 42.21 | 46.22 | 14.11 | 9.09 | |||||
EBITDA, 5 Yr. CAGR % | 19.72 | 16.21 | 12.69 | 46.46 | 15.33 | |||||
EBITA, 5 Yr. CAGR % | 21.51 | 17.65 | 13.89 | 54.88 | 16.82 | |||||
EBIT, 5 Yr. CAGR % | 20.16 | 16.44 | 11.09 | 141.01 | 18.82 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 28.31 | 28.45 | 5.2 | 45.69 | 36.43 | |||||
Net Income, 5 Yr. CAGR % | 28.31 | 28.45 | 5.2 | 48.42 | 36.43 | |||||
Normalized Net Income, 5 Yr. CAGR % | 18.79 | 18.79 | 11.23 | 61.4 | 22.24 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 26.88 | 24.68 | 2.71 | 44.73 | 34.53 | |||||
Accounts Receivable, 5 Yr. CAGR % | 6.87 | 5.27 | 18.29 | 20.75 | 14.93 | |||||
Inventory, 5 Yr. CAGR % | - | - | - | -10.74 | -3.83 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | -0.35 | 0.07 | 1.76 | -0.68 | -0.18 | |||||
Total Assets, 5 Yr. CAGR % | 11.16 | 11.14 | 11.94 | 11.7 | 12.17 | |||||
Tangible Book Value, 5 Yr. CAGR % | 7.57 | 25.25 | 8.4 | 36.37 | 31.41 | |||||
Common Equity, 5 Yr. CAGR % | 12.99 | 15.69 | 13.75 | 18.29 | 20.08 | |||||
Cash From Operations, 5 Yr. CAGR % | 3.73 | 13.28 | 6.99 | 27.99 | 5.54 | |||||
Capital Expenditures, 5 Yr. CAGR % | -25.88 | -27.86 | -29.02 | - | -25.42 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 1.63 | 11.18 | 10.36 | 31.77 | 12.64 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 1.88 | 11.03 | 10.51 | 29.52 | 12.47 | |||||
Dividend Per Share, 5 Yr. CAGR % | 3.55 | 2.59 | 11.7 | - | 10.76 |
- Stock Market
- Stocks
- SAG Stock
- Financials Science Group plc
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















